| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Bacopa Monnieri | Age-Related Cognitive Decline | 1 | PM | 31182153 | 📋 | Efficacy of Cognition Support Formula® on Cognitive Function in Older Adults With Subjective Cognitive Impairment: A Protocol for a 26-week, Randomised, Double-Blind, Placebo-Controlled Trial |
| Bacopa Monnieri | Alzheimer's Disease | 6 | PM | 38143280 | 📋 | Amelioration of Amyloid-β Induced Alzheimer's Disease by Bacopa monnieri through Modulation of Mitochondrial Dysfunction and GSK-3β/Wnt/β-Catenin Signaling |
| Bacopa Monnieri | Alzheimer's Disease | 5 | PM | 37535247 | 📋 | Synergistic neuroprotection by phytocompounds of Bacopa monnieri in scopolamine-induced Alzheimer's disease mice model |
| Bacopa Monnieri | Alzheimer's Disease | 4 | PM | 37315665 | 📋 | Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease |
| Bacopa Monnieri | Alzheimer's Disease | 3 | PM | 36716837 | 📋 | Bacopa monnieri reduces Tau aggregation and Tau-mediated toxicity in cells |
| Bacopa Monnieri | Alzheimer's Disease | 2 | PM | 35559552 | 📋 | Effect of Bacopa Monnieri and Memantine in LPS-induced neuronal toxicity |
| Bacopa Monnieri | Alzheimer's Disease | 1 | PM | 30599045 | 📋 | Medical Plants and Nutraceuticals for Amyloid-β Fibrillation Inhibition |
| Bacopa Monnieri | Autism Spectrum Disorder | 1 | PM | 35346813 | 📋 | Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats |
| Bacopa Monnieri | Depression | 1 | PM | 35413358 | 📋 | Neuroprotective role of Bacopa monnieri extract in modulating depression in an experimental rat model |
| Bacopa Monnieri | Schizophrenia | 1 | PM | 36296643 | 📋 | Bio-Computational Evaluation of Compounds of Bacopa Monnieri as a Potential Treatment for Schizophrenia |
